Supriya Lifescience Limited
Biotechnology · Healthcare
Analyst
iThought PMS
Equibles does not estimate personal net worth.
Sanjay Kumar is recorded as Analyst at iThought PMS. Sanjay Kumar has spoken on 3 earnings calls across 3 companies, most recently for Supriya Lifescience Limited on May 28, 2026. Those appearances were for Supriya Lifescience Limited, Shilpa Medicare Limited and BirlaNu Limited. The companies whose calls Sanjay Kumar spoke on are classified in the Healthcare and Industrials sectors.
“So, first question on the cardiovascular product. I think we had previously indicated that we have a thousand ton capacity of which 300 tons you are in advanced discussions.”
“It seems to be a blockbuster product based on the Phase 2 trials. Yet, despite completing Phase 2 in late 2022, you didn't file for Phase 3 till April 24. You didn't start Phase 3 till Jan 2026.”
“In Q2 call, I think we are committed to about 150 to 200 basis points. Uh, EBITDA improvement from the BCG project. In Q4, on a standalone basis, we did about, uh, 4 percent EBITDA margins.”
iThought PMS
Analyst
Transcript header (unverified)
Supriya Lifescience Limited
Biotechnology · Healthcare
Shilpa Medicare Limited
Drug Manufacturers - Specialty & Generic · Healthcare
BirlaNu Limited
Building Products & Equipment · Industrials
Supriya Lifescience Limited Q4 FY26 Earnings Conference Call
Supriya Lifescience Limited
Earnings Call
Shilpa Medicare Limited
Earnings Call for the Quarter Ended March 31, 2026
BirlaNu Limited